semaglutide do and don't for weight loss in non-diabetics dos and don'ts while taking

ARK Medical of Las Vegas is here for your health needs

Key concerns include gastrointestinal side effects leading to dehydration and electrolyte imbalance, risk of sarcopenia and functional decline from excessive weight loss, drug interactions (particularly with warfarin), and gallbladder disorders

Tirzepatide, a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound), may indirectly affect menstrual cycles in some women

These IV drips provide hydration and nutrients that support energy and overall wellness

Given its dual effect on muscle and fat, ActRII blockade is an attractive adjunct to GLP-1RAs to mitigate lean mass loss